Back to Search
THOMAS MERTZ, DO, PHARMD.
DO, PHARMD.
Allergy & Immunology Physician
NPI: 1942495825IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
046528(CT)
Pediatrics Physician
Pediatrics
Code: 208000000X
046528(CT)
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
OS015695(PA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2004
Research & Publications (10)
Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption.
PMID 18063367·Bioorg Med Chem Lett·2008
7-preclinical
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.
PMID 17574412·Bioorg Med Chem Lett·2007
7-preclinical
Postreplication repair inhibits CAG.CTG repeat expansions in Saccharomyces cerevisiae.
PMID 17060452·Mol Cell Biol·2007
8-other
In vitro and in vivo antithrombotic activity of PD-198961, a novel synthetic factor Xa inhibitor.
PMID 15454859·J Cardiovasc Pharmacol·2004
4-observational
Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
PMID 15267248·J Med Chem·2004
7-preclinical
Assessment of ex vivo pharmacodynamic markers during inhibition of thrombosis by CI-1031 (ZK-807834), a novel direct factor Xa inhibitor.
PMID 11803247·Pharmacology·2002
7-preclinical
The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
PMID 11740955·Eur J Pharmacol·2001
4-observational
Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran.
PMID 11248787·J Thromb Thrombolysis·2001
4-observational
The antithrombotic effects of CI-1028, an orally bioavailable direct thrombin inhibitor, in a canine model of venous and arterial thrombosis.
PMID 11122549·J Thromb Thrombolysis·2000
4-observational
Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
PMID 11063603·J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2585 FREEPORT RD STE 210
PITTSBURGH, PA 15238 - Phone
- (412) 828-3800
Quick Facts
- NPI
- 1942495825
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 22
- Publications
- 10
Are you this provider?
Claim Your Profile